Over the past decade, the development of digital medicines has been steadily gaining momentum, with real-world data demonstrating that these approaches can help improve patient lives. The COVID-19 pandemic further propelled the digital medicines industry forward by shining a light on the need for innovative treatment options and accelerating the adoption of technologies that integrate healthcare into daily life. Digital medicines have the potential to transform healthcare but remain an emerging field that is still being defined. For developers who are exploring this frontier, this checklist provides an overview of key considerations for bringing digital therapeutic innovations successfully to market.
